TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.

Trial Profile

TOPical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasm: a Randomized Controlled Trial.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Imiquimod (Primary)
  • Indications Cervical intraepithelial neoplasia
  • Focus Therapeutic Use
  • Acronyms TOPIC
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 20 Jun 2016 Status changed from recruiting to discontinued.
    • 20 Feb 2016 Trial design published in BMC Cancer.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top